Birch pollen allergy vaccine (Anergis)

N/A

Report date: 2022/11/25 17:58:15

Base Information

Drug NameBirch pollen allergy vaccine (Anergis)
Drug Alias NameAllerT-Birch桦树花粉过敏疫苗 - AnergisAllerT
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHypersensitivityConjunctivitis, AllergicRhinitis, Allergic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaSlovakiaSweden +[12] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Lausanne
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnergis Sa
Active IndicationsN/A
Inactive IndicationsHypersensitivityConjunctivitis, AllergicRhinitis, Allergic +[4] 

Other Information

ATC CodeN/A
Related LinksN/A